02/23/2026 07:00
AGCO Power’s Core80 Engine Named Diesel Engine of the Year 2026

Developed and manufactured in Linnavuori, Finland, the engine represents the most advanced technology in AGCO Power’s new Core engine family. The award is among the most respected in the industry and has been recognizing groundbreaking off‑highway powertrain innovations for 20 years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260222724310/en/Powertrain International Editor-in-Chief Fabio Butturi (left) presents the Diesel Engine...

02/12/2026 02:00
FPT Recognized in Gartner® Market Guide for Microsoft 365 Implementation and Support Services 2026

FPT, a global technology and IT services provider, has been listed among 14 Representative Vendors in the Gartner® Market Guide for Microsoft 365 Implementation and Support Services 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211829399/en/ As a Microsoft strategic partner for more than 25 years, FPT covers the full Microsoft stack, including Azure, Microsoft 365, Power Platform, Dynamics 365, and cloud security. The comp...

02/12/2026 04:13
Lenovo Group: Third Quarter Financial Results 2025/26

Lenovo Group Limited (HKSE: 992) (ADR: LNVGY), together with its subsidiaries (‘the Group’), today reported results for the third quarter of fiscal year 2025/26, a quarter that delivered record revenues, accelerated profitability, and continued AI revenue expansion. During the quarter, overall group revenue reached an all-time fiscal quarter high of US$22.2 billion, up 18% year-on-year, with revenue from all business groups growing double-digit year-on-year. Excluding non-operating non-cash ite...

02/19/2026 11:00
YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency

YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene editing therapies, today announced positive interim data from an investigator-initiated trial (IIT) of YOLT-202, the Company’s investigational in vivo base editing therapy, for the treatment of Alpha-1 Antitrypsin Deficiency (AATD) that demonstrated positive safety and tolerability as well as meaningful increases in AAT levels in evaluated patients treated with the 35 mg and 45 mg dose levels. “These int...

02/23/2026 07:55
AHS Tower Fully Sold During Development, Generating More Than USD 700 Million

AHS Properties has confirmed that 100 percent of inventory at AHS Tower has been sold, generating more than USD 700 million in revenue during the development phase, a clear indicator of strong market demand for its flagship commercial project. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260222540070/en/AHS Tower Fully Sold During Development on Sheikh Zayed Road (Photo: AETOSWire) Rising 69 storeys above Sheikh Zayed Road, the to...

02/07/2026 15:41
DCO Concludes 5th General Assembly with Adoption of the Kuwait Declaration on Responsible AI for Global Digital Prosperity

The Digital Cooperation Organization (DCO) has concluded its fifth General Assembly, with Member States adopting the Kuwait Declaration on Responsible AI for Global Digital Prosperity and agreeing on actions to advance inclusive, trusted, and scalable digital transformation in the AI age. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260207972901/en/DCO concludes 5th General Assembly with adoption of the Kuwait Declaration on Respo...

02/12/2026 06:00
We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties

Galderma (SIX: GALD), the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra® across nine diverse patients – who were all new to injectable aesthetics – over two years.1 This innovative initiative will offer a rare and authentic real-life perspective on the power of regenerative biostimulation to deliver personalized outcomes, and demonstrate how Sculptra adapts to different skin types, life stages, and...

02/12/2026 06:01
AB InBev Reports Full Year and Fourth Quarter 2025 Results

Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211688662/en/Figure 14. Terms and debt repayment schedule as of 31 December 2025 (billion USD) Regulated and inside information1 “Beer plays an important role in bringing people together and creating moments of celebration. In 2025, we executed our strategy, made disciplined capital allocation choices and delivered ...

02/12/2026 06:00
Bardasz Forms Strategic Digital Alliance with GEOLOG to Accelerate Global RTOC Delivery and Digital Well Construction Solutions

Bardasz Group LLC (“Bardasz”), a provider of real-time, decision-ready intelligence for well construction—including drilling, completions, and well interventions—today announced a strategic digital alliance with GEOLOG International B.V. (“GEOLOG”), a global formation evaluation, drilling, and geochemistry services provider supporting subsurface projects in more than 40 countries. The alliance is designed to accelerate Bardasz’s global growth and enhance customer delivery by leveraging GEOLOG...

02/23/2026 09:00
AOP Health on Rare Diseases: Information. Collaboration. Innovation.

Between 27 and 36 million1 people in Europe are living with a rare disease, yet only around six percent currently have access to an approved treatment2. Progress in diagnosis and treatment is often slowed by knowledge gaps, including the lack of clear, reliable, and patient-friendly information needed to support informed decision-making. Drawing on 30 years of experience in researching and developing therapies for rare diseases, AOP Health underscores the importance of collaboration across the ...